title: [The role of RPA classification in the treatment of high-grade gliomas].
abstract: One of the main gliomas treatment programs development criteria is still the morphology, the RPA classification with risk factors developed for high-grade tumors is rarely taken into consideration. In our study shows a high value on the criterion of overall survival identified in the classification of the six RPA classes. The most important factors in the RPA classification are patient's age and the Karnofsky performance scale value. RPA classification can be useful for new treatment strategies development.
authors.forename: T R
authors.initials: TR
authors.lastname: Izmaĭlov
authors.forename: G A
authors.initials: GA
authors.lastname: Pan'shin
authors.forename: P V
authors.initials: PV
authors.lastname: Datsenko
authors.forename: V K
authors.initials: VK
authors.lastname: Zotov
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D001932:Brain Neoplasms / Q000401:mortality / Q000473:pathology* / Q000503:physiopathology; D002648:Child; D005260:Female; D005910:Glioma / Q000401:mortality / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D053208:Kaplan-Meier Estimate; D017567:Karnofsky Performance Status; D008297:Male; D008875:Middle Aged; D060787:Neoplasm Grading; D011237:Predictive Value of Tests; D011379:Prognosis; D012307:Risk Factors; D012426:Russia / Q000453:epidemiology